Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Vision HexaCard

Genomic Vision has launched HexaCard, a new service for the control and optimization of genome editing. Primarily for gene therapy and biomanufacturing, HexaCard addresses challenges of cellular cross-contamination, misidentified cell lines, and the use of cell cultures at high passage. Based on Genomic Visions' proprietary Molecular Combing Technology, it integrates copy number determination, orientation assessment, integration site identification, genetic integrity of the target region, on- and off-target insertions, and a genetic signature for stability assessment into a single assay.